KBI Biopharma acquires Merck’s biomanufacturing facility in Colorado

By Zachary Brennan

- Last updated on GMT

KBI Biopharma acquires Merck’s biomanufacturing facility in Colorado

Related tags: Steel

KBI Biopharma has agreed to acquire Merck’s microbial process development and manufacturing operations in Boulder, Colorado. 

Under the agreement, KBI will provide ongoing development and manufacturing services to Merck, as well as to third party customers.

The 80,000 square foot space is spread across three buildings with research labs attached to it, KBI spokesman Andrew Cohen told us.

Joe McMahon, KBI’s President and CEO, noted, “KBI will now offer expanded microbial development and manufacturing services up to 1500L scale, as well as continuing to offer our current full range of process development, analytical and formulation development and mammalian manufacturing services up to 2000L​.”

The site offers stainless steel bioreactors, Cohen added, noting that the company’s sites in North Carolina uses single use bioreactors.

There’s still open capacity as we go through this transition​,” Cohen said.

KBI will also continue to support other ongoing drug development programs for Merck from its two North Carolina facilities.

To date, KBI has helped to advance more than 220 molecules in 55 unique health indications for over 170 clients worldwide.  

Related news

Show more

Related products

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 01-Jan-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us

Products

View more

Webinars